Target |
Mechanism MAO-A inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism MAO-A inhibitors [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism MAO-A inhibitors [+1] |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc. US |
First Approval Date01 Jan 1982 |
Start Date01 Feb 2012 |
Sponsor / Collaborator |
Start Date01 Feb 2011 |
Sponsor / Collaborator |
Start Date01 Oct 2009 |
Sponsor / Collaborator Vernalis (R&D) Ltd. [+1] |